11-1f4
mAbexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT01815086)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Beta amyloid A4 proteinINHIBITOR
APP inhibitor
- Light chain aggregatesINHIBITOR
Light chain aggregates inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109302 ↗
Also known as
- 11-1f4
- mu-11-1f4
- mu-11-1f4 124i
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02245867 | Phase 1 | Sep 1, 2014 | Columbia University |
| NCT01815086 | Phase 1 | Dec 1, 2008 | Food and Drug Administration, University of Tennessee |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Columbia University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Food and Drug Administration | Government | 1 | 0 | 1 | 2008 |
| University of Tennessee | Academic/Hospital | 1 | 1 | 1 | 2008 |
3 organizations
Page 1 / 1